In-hospital major bleeding and its clinical relevance in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention

American Journal of Cardiology

Volumn 112, Issue 10, 2013, Pages 1533-1539

  Boden, Helèn ^a   Velders, Matthijs A ^a   Van Der Hoeven, Bas L ^a   Cannegieter, Suzanne C ^a   Schalij, Martin J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLEEDING; BLEEDING ACADEMIC RESEARCH CONSORTIUM; BRAIN DISEASE; CAN RAPID RISK STRATIFICATION OF UNSTABLE ANGINA PATIENTS SUPPRESS ADVERSE OUTCMOES WITH EARLY IMPLEMENTATION OF THE ACC AHA GUIDELINES; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GLOBAL USE OF STRATEGIES TO OPEN CORONARY ARTERIES; HEART FAILURE; HEART RATE; HEART VENTRICLE SEPTUM RUPTURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IN HOSPITAL MAJOR BLEEDING; INCIDENCE; KIDNEY FAILURE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUT OF HOSPITAL CARDIAC ARREST; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECURRENT DISEASE; SCORING SYSTEM; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THROMBOLYSIS IN MYOCARDIAL INFARCTION; THROMBOSIS; TREATMENT FAILURE; VASCULAR ACCESS; VASCULAR DISEASE;

ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; INCIDENCE; INPATIENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 84887021372     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.06.025     Document Type: Article

References (27)

1. H. Boden, B.L. van der Hoeven, I. Karalis, M.J. Schalij, and J.W. Jukema Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment J Intern Med 271 2012 521 536
2. P.G. Steg, K. Huber, F. Andreotti, H. Arnesen, D. Atar, L. Badimon, J.P. Bassand, C.R. De, J.A. Eikelboom, D. Gulba, M. Hamon, G. Helft, K.A. Fox, S.D. Kristensen, S.V. Rao, F.W. Verheugt, P. Widimsky, U. Zeymer, and J.P. Collet Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology Eur Heart J 32 2011 1854 1864
3. S. Subherwal, R.G. Bach, A.Y. Chen, B.F. Gage, S.V. Rao, L.K. Newby, T.Y. Wang, W.B. Gibler, E.M. Ohman, M.T. Roe, C.V. Pollack Jr., E.D. Peterson, and K.P. Alexander Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score Circulation 119 2009 1873 1882
4. R. Mehran, S.J. Pocock, E. Nikolsky, T. Clayton, G.D. Dangas, A.J. Kirtane, H. Parise, M. Fahy, S.V. Manoukian, F. Feit, M.E. Ohman, B. Witzenbichler, G. Guagliumi, A.J. Lansky, and G.W. Stone A risk score to predict bleeding in patients with acute coronary syndromes J Am Coll Cardiol 55 2010 2556 2566
5. B.J. Doyle, H.H. Ting, M.R. Bell, R.J. Lennon, V. Mathew, M. Singh, D.R. Holmes, and C.S. Rihal Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005 JACC Cardiovasc Interv 1 2008 202 209
6. F.A. Spencer, M. Moscucci, C.B. Granger, J.M. Gore, R.J. Goldberg, P.G. Steg, S.G. Goodman, A. Budaj, G. FitzGerald, and K.A. Fox Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 116 2007 2793 2801
7. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
8. W. Hochholzer, S.D. Wiviott, E.M. Antman, C.F. Contant, J. Guo, R.P. Giugliano, A.J. Dalby, G. Montalescot, and E. Braunwald Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel - Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38) Circulation 123 2011 2681 2689
9. S.S. Liem, B.L. van der Hoeven, P.V. Oemrawsingh, J.J. Bax, J.G. van der Bom, J. Bosch, E.P. Viergever, R.C. van, I. Padmos, M.I. Sedney, H.J. van Exel, H.F. Verwey, D.E. Atsma, E.T. van der Velde, J.W. Jukema, E.E. van der Wall, and M.J. Schalij MISSION!: optimization of acute and chronic care for patients with acute myocardial infarction Am Heart J 153 2007 14.e1 14.e11
10. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, H.D. White, K. Thygesen, J.S. Alpert, H.D. White, A.S. Jaffe, H.A. Katus, F.S. Apple, B. Lindahl, D.A. Morrow, B.R. Chaitman, P.M. Clemmensen, P. Johanson, H. Hod, R. Underwood, J.J. Bax, J.J. Bonow, F. Pinto, R.J. Gibbons, K.A. Fox, D. Atar, L.K. Newby, M. Galvani, C.W. Hamm, B.F. Uretsky, P.G. Steg, W. Wijns, J.P. Bassand, P. Menasche, J. Ravkilde, E.M. Ohman, E.M. Antman, L.C. Wallentin, P.W. Armstrong, M.L. Simoons, J.L. Januzzi, M.S. Nieminen, M. Gheorghiade, G. Filippatos, R.V. Luepker, S.P. Fortmann, W.D. Rosamond, D. Levy, D. Wood, S.C. Smith, D. Hu, J.L. Lopez-Sendon, R.M. Robertson, D. Weaver, M. Tendera, A.A. Bove, A.N. Parkhomenko, E.J. Vasilieva, S. Mendis, J.J. Bax, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, A. Torbicki, A. Vahanian, S. Windecker, J. Morais, C. Aguiar, W. Almahmeed, D.O. Arnar, F. Barili, K.D. Bloch, A.F. Bolger, H.E. Botker, B. Bozkurt, R. Bugiardini, C. Cannon, L.J. de, F.R. Eberli, E. Escobar, M. Hlatky, S. James, K.B. Kern, D.J. Moliterno, C. Mueller, A.N. Neskovic, B.M. Pieske, S.P. Schulman, R.F. Storey, K.A. Taubert, P. Vranckx, and D.R. Wagner Third universal definition of myocardial infarction J Am Coll Cardiol 60 2012 1581 1598
11. A.K. Rao, C. Pratt, A. Berke, A. Jaffe, I. Ockene, T.L. Schreiber, W.R. Bell, G. Knatterud, T.L. Robertson, and M.L. Terrin Thrombolysis in Myocardial Infarction (TIMI) Trial - phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11
12. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators N Engl J Med 329 1993 673 682
13. R. Mehran, S.V. Rao, D.L. Bhatt, C.M. Gibson, A. Caixeta, J. Eikelboom, S. Kaul, S.D. Wiviott, V. Menon, E. Nikolsky, V. Serebruany, M. Valgimigli, P. Vranckx, D. Taggart, J.F. Sabik, D.E. Cutlip, M.W. Krucoff, E.M. Ohman, P.G. Steg, and H. White Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
14. D.J. Quinlan, J.W. Eikelboom, S.G. Goodman, R.C. Welsh, D.H. Fitchett, P. Theroux, and S.R. Mehta Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes Eur Heart J 32 2011 2256 2265
15. E. Nikolsky, R. Mehran, G. Dangas, M. Fahy, Y. Na, S.J. Pocock, A.M. Lincoff, and G.W. Stone Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach Eur Heart J 28 2007 1936 1945
16. M.A. Velders, H. Boden, A.J. van Boven, B.L. van der Hoeven, A.A. Heestermans, S.C. Cannegieter, V.A. Umans, J.W. Jukema, S.H. Hofma, and M.J. Schalij Influence of gender on ischemic times and outcomes after ST-elevation myocardial infarction Am J Cardiol 111 2013 312 318
17. R. Mehran, S. Pocock, E. Nikolsky, G.D. Dangas, T. Clayton, B.E. Claessen, A. Caixeta, F. Feit, S.V. Manoukian, H. White, M. Bertrand, E.M. Ohman, H. Parise, A.J. Lansky, A.M. Lincoff, and G.W. Stone Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials JACC Cardiovasc Interv 4 2011 654 664
18. R.S. Hermanides, J.P. Ottervanger, J.H. Dambrink, M.J. de Boer, J.C. Hoorntje, A.T. Gosselink, H. Suryapranata, and A.W. van 't Hof Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction EuroIntervention 6 2010 106 111
19. R.D. Lopes, S. Subherwal, D.N. Holmes, L. Thomas, T.Y. Wang, S.V. Rao, O.E. Magnus, M.T. Roe, E.D. Peterson, and K.P. Alexander The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction Eur Heart J 33 2012 2044 2053
20. O. Barthelemy, J. Silvain, D. Brieger, A. Mercadier, R. Lancar, A. Bellemain-Appaix, F. Beygui, J.P. Collet, D. Costagliola, and G. Montalescot Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center Catheter Cardiovasc Interv 79 2012 104 112
21. G. Ndrepepa, T. Schuster, M. Hadamitzky, R.A. Byrne, J. Mehilli, F.J. Neumann, G. Richardt, S. Schulz, K.L. Laugwitz, S. Massberg, A. Schomig, and A. Kastrati Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention Circulation 125 2012 1424 1431
22. G. Ndrepepa, P.B. Berger, J. Mehilli, M. Seyfarth, F.J. Neumann, A. Schomig, and A. Kastrati Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697
23. B.J. Doyle, C.S. Rihal, D.A. Gastineau, and D.R. Holmes Jr. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice J Am Coll Cardiol 53 2009 2019 2027
24. S.V. Rao, J.G. Jollis, R.A. Harrington, C.B. Granger, L.K. Newby, P.W. Armstrong, D.J. Moliterno, L. Lindblad, K. Pieper, E.J. Topol, J.S. Stamler, and R.M. Califf Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562
25. S.R. Mehta, S.S. Jolly, J. Cairns, K. Niemela, S.V. Rao, A.N. Cheema, P.G. Steg, W.J. Cantor, V. Dzavik, A. Budaj, M. Rokoss, V. Valentin, P. Gao, and S. Yusuf Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation J Am Coll Cardiol 60 2012 2490 2499
26. K.P. Alexander, and E.D. Peterson Minimizing the risks of anticoagulants and platelet inhibitors Circulation 121 2010 1960 1970
27. D.R. Tavris, Y. Wang, S. Jacobs, B. Gallauresi, J. Curtis, J. Messenger, F.S. Resnic, and S. Fitzgerald Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies J Invasive Cardiol 24 2012 328 334